Disclosure. Relevant Financial Relationship(s) None. Off Label Usage None MFMER slide-1
|
|
- Mervyn Lindsey
- 5 years ago
- Views:
Transcription
1 Disclosure Relevant Financial Relationship(s) None Off Label Usage None 2013 MFMER slide-1
2 Case Presentation A 43 year old male, with partial nephrectomy for a right kidney mass 2013 MFMER slide-2
3 2013 MFMER slide-3
4 2013 MFMER slide-4
5 2013 MFMER slide-5
6 Morphologic diagnosis: A. Clear cell renal cell carcinoma B. Papillary carcinoma C. Mixed epithelial stromal tumor D. Clear cell tubulopapillary renal cell carcinoma E. Tubulocystic renal cell carcinoma 2013 MFMER slide-6
7 Immunohistochemistry CK7 CK903 RCMS 2013 MFMER slide-7
8 DIAGNOSIS Clear cell (tubulo)papillary renal cell carcinoma 2013 MFMER slide-8
9 New (and refined) entities in the ISUP Vancouver and WHO 2016 Classification of Renal Neoplasia Rafael E. Jiménez 2013 MFMER slide-9
10 2013 MFMER slide-10
11 New Renal Epithelial Tumor Categories Tubulocystic renal cell carcinoma Acquired cystic disease-associated renal cell carcinoma Clear cell (tubulo)papillary renal cell carcinoma MiT family translocation carcinomas Xp11 tranlocation RCC (*) t(6;11) RCC Hereditary leiomyomatosis-rcc syndromeassociated RCC Succinate dehydrogenase-deficient RCC (*) already included in 2004 WHO classif 2013 MFMER slide-11
12 Tubulocystic carcinoma Previously considered as a low grade variant of collecting duct carcinoma. >70 cases reported Usually present in low stages (pt1-pt2). Well circumscribed, encapsulated, bubble wrap cut surface 2013 MFMER slide-12
13 2013 MFMER slide-13
14 2013 MFMER slide-14
15 Appl Immunohistochem Mol Morphol Aug;24(7): TC-RCC demonstrates variable status of chromosomes 7, 17, and Y even in cases with typical/uniform morphology. The biological nature of Papillary RCC or High-grade NOS RCClike areas within TC-RCC remains unclear. Heterogeneous TC-RCCs may be associated with an adverse clinical outcome. HG TC-RCC indistinguishable from HLRCC 2013 MFMER slide-15
16 Tubulocystic RCC Dx should be restricted to pure cases >90% indolent behavior Distant metastasis and death described in 4 cases MFMER slide-16
17 Clear cell tubulopapillary RCC Initially reported in end stage kidneys, however majority are sporadic. Variable papillary, tubular/acinar, cystic architecture. May contain dense muscular stroma (RAT). Linear arrangement of low grade nuclei away from base MFMER slide-17
18 2013 MFMER slide-18
19 Clear cell tubulopapillary RCC 2013 MFMER slide-19
20 Clear cell tubulopapillary RCC IHC Profile Diffuse CK7 CD10 negative Diffuse CA-IX (cup shaped distribution) Negative racemase Patchy to diffuse 34BE12 Prognosis Indolent clinical behavior No metastases reported in pure tumors One case with sarcomatoid change, metastases, and DOD recently reported 2013 MFMER slide-20
21 CCTP-RCC CC-RCC 2013 MFMER slide-21
22 Am J Surg Pathol 2015;39: cases with morphologic overlap with CC TubPap-RCC Atypical features, including labeling for CD10 and AMACR, higher nuclear grade and tumor stage, and tumor necrosis. The majority of such tumors demonstrated abnormalities of chromosome 3p by FISH or karyotyping, arguing that they are best regarded as a manifestation of clear cell renal cell carcinoma MFMER slide-22
23 Translocation-associated carcinomas Translocations involving Xp11.2 (TFE3). ASPL-TFE3 PRCC-TLFE3 Translocation involving TFEB [t(6;11)] TFE3 and TFEB part of the MiT subfamily of transcription factors 50% of RCC of pediatric age. <5% of adult RCC 2013 MFMER slide-23
24 Translocation Xp11 RCC ASPL-TFE3 PRCC-TFE MFMER slide-24
25 2013 MFMER slide-25
26 Translocation Xp11RCC IHC Profile Focal or negative expression of keratins and EMA RCC, CD10, PAX2 positive Strong nuclear TFE3 immunoreactivity Keratin - Negative TFE MFMER slide-26
27 2013 MFMER slide-27
28 Translocation Xp11 RCC Prognosis Usually present with high stage Children good prognosis despite high stage Not enough long term survival data Adults 1-2 years survival Late recurrences (20-30 years) 2013 MFMER slide-28
29 t(6;11) RCC Mean age 28.5 years Alpha-TFEB gene fusion. Biphasic morphology: large and small cells Basement membrane material Express melanocytic markers Negative for cytokeratins 10% metastatic and death rate in reported cases Image from: Magers et al, Arch Pathol Lab Med. 2015;139: MFMER slide-29
30 Acquired Cystic Disease-Associated RCC Most common neoplasm in the end-stage kidney setting Arise from cyst wall or adjacent parenchyma Multifocality and bilaterality IHC Profile Diffusely for racemase Negative CK7 Relatively good prognosis, although sarcomatoid and rhabdoid change may occur Sieve-like appearance 2013 MFMER slide-30
31 Acquired Cystic Disease-Associated RCC Calcium oxalate crystals 2013 MFMER slide-31
32 Precursor multicystic lesions End-stage kidney background 2013 MFMER slide-32
33 Hereditary Leiomyomatosis-related RCC Autosomal dominant mutations in the fumarate hydratase gene Smooth muscle and renal neoplasms Highly aggressive renal neoplasms High-grade with inclusionlike nucleoli surrounded by halo 2013 MFMER slide-33
34 Papillae (previously papillary RCC or CDC) Tubulocystic 2013 MFMER slide-34
35 Succinate-dehydrogenase-deficient RCC Part of spectrum of tumors developed by patients with germline mutations of SDH, which also include paragangliomas and GISTS. Oncocytic tumor with characteristic cytoplasmic vacuolization Other SDH-deficient histologies being identified, but rare MFMER slide-35
36 SDH-deficient RCC Typical vacuolated cytoplasm with floculent inclusions Absent staining in tumor cells with SDHB At least one case with widespread metastasis and DOD reported, although majority low grade, indolen 2013 MFMER slide-36
37 2013 MFMER slide-37
38 Refinement of concepts on old entities Clear cell renal cell carcinoma: Multilocular cystic renal cell neoplasm of low malignant potential Chromophobe renal cell carcinoma: Hybrid oncocytic tumors 2013 MFMER slide-38
39 Multilocular cystic renal cell neoplasm of low malignant potential Numerous cysts, the septa of which contain small groups of clear cells grade I Cysts lined by clear cells. No solid areas with expansive nodules Excellent prognosis >200 patients with f/u >5 years 2013 MFMER slide-39
40 2013 MFMER slide-40
41 2013 MFMER slide-41
42 2013 MFMER slide-42
43 Oncocytosis Oncocytic tumors and other oncocytic changes in the renal parenchyma: Oncocytomas Chromophobe carcinomas Hybrid tumors Oncocytic change in medullary tubules 2013 MFMER slide-43
44 Hybrid oncocytic tumors Oncocytomas with focal atypia Well-defined nests, but cellular atypia. Classic cytologic features of oncocytoma, but loss of the nested architecture. Others exhibit well-defined areas of chromophobe carcinoma, coexisting with classic areas of oncocytoma MFMER slide-44
45 2013 MFMER slide-45
46 2013 MFMER slide-46
47 2013 MFMER slide-47
48 2013 MFMER slide-48
49 Summary The Vancouver ISUP classification of renal neoplasia and the 2016 WHO classification define new entities readily identifiable on morphologic basis. Selected concepts on well-established diagnostic categories continue further refinement. Unresolved issues on kidney tumor categories guarantees further updates and revisions of renal neoplasia classification 2013 MFMER slide-49
Renal tumours: use of immunohistochemistry & molecular pathology. Dr Lisa Browning John Radcliffe Hospital Oxford
Renal tumours: use of immunohistochemistry & molecular pathology Dr Lisa Browning John Radcliffe Hospital Oxford Renal tumours: the use of immunohistochemistry & molecular pathology Classification of RCC
More informationWhat s New in Pathology of Genitourinary Tumors. Jiaoti Huang, MD, PhD Department of Pathology Duke University School of Medicine
What s New in Pathology of Genitourinary Tumors Jiaoti Huang, MD, PhD Department of Pathology Duke University School of Medicine Kidney Tumors Multilocular cystic renal neoplasm of low malignant potential
More informationVarious hereditary, acquired and neoplastic conditions can lead to cyst formation in the kidney.
Dr. Fatima AlAl-Hashimi Hashimi,, MD, FRCPath Salmaniya Medical Complex, Bahrain Various hereditary, acquired and neoplastic conditions can lead to cyst formation in the kidney. The most frequently encountered
More informationDIAGNOSTIC SLIDE SEMINAR: PART 1 RENAL TUMOUR BIOPSY CASES
DIAGNOSTIC SLIDE SEMINAR: PART 1 RENAL TUMOUR BIOPSY CASES Dr. Andrew J. Evans MD, PhD, FACP, FRCPC Consultant in Genitourinary Pathology University Health Network, Toronto, ON Case 1 43 year-old female,
More informationDiagnostic accuracy of percutaneous renal tumor biopsy May 10 th 2018
Diagnostic accuracy of percutaneous renal tumor biopsy May 10 th 2018 Dr. Tzahi Neuman Dep.Of Pathology Hadassah Medical Center Jerusalem, Israel, (tneuman@hadassah.org.il) Disclosure: 1 no conflicts of
More informationACCME/Disclosures. M31078/07 Ondřej Hes 4/13/2016
M31078/07 Ondřej Hes Department of Pathology Charles University and University Hospital Plzeň Bioptická laboratoř Plzeň Czech Republic ACCME/Disclosures The USCAP requires that anyone in a position to
More informationRENAL NEOPLASMS: NEW ENTITIES & DIFFICULT DIAGNOSES
RENAL NEOPLASMS: NEW ENTITIES & DIFFICULT DIAGNOSES Cristina Magi-Galluzzi, MD, PhD Professor of Pathology Director of Anatomic Pathology Kidney Tumors American Cancer Society Cancer Facts and Figures
More informationSpectrum of Preneoplastic and Neoplastic Cystic Lesions of the Kidney in Adult. by dr. Banan Burhan Mohammed Lecturer in Pathology Department
Spectrum of Preneoplastic and Neoplastic Cystic Lesions of the Kidney in Adult by dr. Banan Burhan Mohammed Lecturer in Pathology Department Various hereditary, acquired, and neoplastic conditions can
More informationEnterprise Interest Nothing to declare
Enterprise Interest Nothing to declare Biopsy diagnosis of renal tumors. Current applications Ondřej Hes Department of Pathology Charles University and University Hospital Plzeň Czech Republic Dealing
More informationIMMUNOPROFILES OF THE MAJOR RENAL NEOPLASMS (%staining)
Stain Clear Cell Papillary IMMUNOPROFILES OF THE MAJOR RENAL NEOPLASMS (%staining) Chromophobe Collecting Duct Carcinom a Sarcomatoid Xp11 Translocat ion Dr Jon Oxley See also www.jonoxley.com Page 1 MTSCC
More information04/10/2018. What s new in renal tumor pathology what s important and why. Prognostic factors in RCC
25th Annual Seminar in Pathology Pittsburgh, PA, April 26-29, 2018 What s new in renal tumor pathology what s important and why Kiril Trpkov, MD FRCPC Department of Pathology and Laboratory Medicine kiril.trpkov@cls.ab.ca
More informationMolecular genetics and immunohistochemistry characterization of uncommon and recently described renal cell carcinomas
Review Article Molecular genetics and immunohistochemistry characterization of uncommon and recently described renal cell carcinomas Qiu Rao 1 *, Qiu-Yuan Xia 1 *, Liang Cheng 2, Xiao-Jun Zhou 1 1 Department
More informationCase 1 PLEASE TURN OFF YOUR CELL PHONES 3/28/2017. Disclosure of Relevant Financial Relationships. Disclosure of Relevant Financial Relationships
PLEASE TURN OFF YOUR CELL PHONES Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position to influence or control the content of CME disclose
More informationRENAL EPITHELIAL NEOPLASMS: IS THERE A ROLE OF IMMUNOSTAINS IN DIAGNOSIS?
RENAL EPITHELIAL NEOPLASMS: IS THERE A ROLE OF IMMUNOSTAINS IN DIAGNOSIS? John C. Cheville, M.D. Mayo Clinic and Mayo Foundation Rochester, MN The majority of renal epithelial neoplasms are diagnosed on
More informationSynonyms. Nephrogenic metaplasia Mesonephric adenoma
Nephrogenic Adenoma Synonyms Nephrogenic metaplasia Mesonephric adenoma Definition Benign epithelial lesion of urinary tract with tubular, glandular, papillary growth pattern Most frequently in the urinary
More informationUpdated Classification of Renal cell carcinoma
Updated Classification of Renal cell carcinoma Suchin Worawichawong, M.D., FRCPath (Thailand) Department of Pathology, Ramathibodi Hospital, Mahidol University Incidence: Global: 338,000 new cases, 130,000
More informationCase presentations 04/10/ th Annual Seminar in Pathology Pittsburgh, PA, April 26-29, 2018
25th Annual Seminar in Pathology Pittsburgh, PA, April 26-29, 2018 Case presentations Kiril Trpkov, MD FRCPC Department of Pathology and Laboratory Medicine kiril.trpkov@cls.ab.ca 45 y/o male, pink tumor,
More informationPapillary Lesions of the Breast A Practical Approach to Diagnosis. (Arch Pathol Lab Med. 2016;140: ; doi: /arpa.
Papillary Lesions of the Breast A Practical Approach to Diagnosis (Arch Pathol Lab Med. 2016;140:1052 1059; doi: 10.5858/arpa.2016-0219-RA) Papillary lesions of the breast Span the spectrum of benign,
More informationUpdates in Urologic Pathology WHO Made Those Changes?! Peyman Tavassoli Pathology Department BC Cancer Agency
Updates in Urologic Pathology WHO Made Those Changes?! Peyman Tavassoli Pathology Department BC Cancer Agency World Health Organization Available in Feb 2016 Frame work for reporting Major contributing
More information04/09/2018. Salivary Gland Pathology in the Molecular Era Old Friends, Old Foes, & New Acquaintances
Salivary Gland Pathology in the Molecular Era Old Friends, Old Foes, & New Acquaintances Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology Chair of Pathology and Laboratory
More informationSelect problems in cystic pancreatic lesions
Disclosure Select problems in cystic pancreatic lesions Five Prime Therapeutics shareholder Adicet Bio shareholder Bristol-Meyer Squibb advisory board grace.kim@ucsf.edu Pancreatic cystic lesions Intraductal
More informationACCME/Disclosures. Diagnosing Mesothelioma in Limited Tissue Samples. Papanicolaou Society of Cytopathology Companion Meeting March 12 th, 2016
Diagnosing Mesothelioma in Limited Tissue Samples Papanicolaou Society of Cytopathology Companion Meeting March 12 th, 2016 Sanja Dacic, MD, PhD University of Pittsburgh ACCME/Disclosures GENERAL RULES
More informationEDUCATIONAL CASES E1 & E2. Natasha Inglis 20/03/15
EDUCATIONAL CASES E1 & E2 Natasha Inglis 20/03/15 CASE E1 79 year old female Rectum. Altemeier operation Histology Superficial erosions and mucosal congestion volcano lesion and pseudomembrane formation
More informationPathology of the Thyroid
Pathology of the Thyroid Thyroid Carcinoma Arising from Follicular Cells 2015-01-19 Prof. Dr. med. Katharina Glatz Pathologie Carcinomas Arising from Follicular Cells Differentiated Carcinoma Papillary
More informationPapillary Lesions of the Breast: WHO Update
Papillary Lesions of the Breast: WHO Update Stuart J. Schnitt, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA, USA Papillary Lesions of the Breast
More informationLecture: Dr Ming Zhou, Cleveland Clinic, Cleveland, Ohio, USA Uncommon renal tumour: Morphologic and molecular characteristics
Australasian Division of the International Academy of Pathology Limited 35 th Annual Scientific Meeting June 4-6, 2010 Venue: Sydney Convention & Exhibition Centre, Darling Harbour, NSW International Society
More informationPathology Mystery and Surprise
Pathology Mystery and Surprise Tim Smith, MD Director Anatomic Pathology Medical University of South Carolina Disclosures No conflicts to declare Some problem cases Kidney tumor Scalp tumor Bladder tumor
More informationCase Report Pediatric Papillary Renal Cell Carcinoma in a Horseshoe Kidney: A Case Report with Review of the Literature
Case Reports in Pathology Volume 2015, Article ID 841237, 4 pages http://dx.doi.org/10.1155/2015/841237 Case Report Pediatric Papillary Renal Cell Carcinoma in a Horseshoe Kidney: A Case Report with Review
More informationOvarian Clear Cell Carcinoma
Ovarian Clear Cell Carcinoma Rouba Ali-Fehmi, MD Professor of Pathology The Karmanos Cancer Institute, Wayne State University School of Medicine 50 year old woman with chief complaint of shortness of breath
More informationKidney Case 1 SURGICAL PATHOLOGY REPORT
Kidney Case 1 Surgical Pathology Report February 9, 2007 Clinical History: This 45 year old woman was found to have a left renal mass. CT urography with reconstruction revealed a 2 cm medial mass which
More informationRenal Neoplasia: Diagnostic Problems and Recently Recognized Entities
Renal Neoplasia: Diagnostic Problems and Recently Recognized Entities John N. Eble, M.D. Department Pathology Indiana University, Indianapolis, IN Holger Moch, M.D. Department Pathology University Hospital
More informationObjectives. Salivary Gland FNA: The Milan System. Role of Salivary Gland FNA 04/26/2018
Salivary Gland FNA: The Milan System Dr. Jennifer Brainard Section Head Cytopathology Cleveland Clinic Objectives Introduce the Milan System for reporting salivary gland cytopathology Define cytologic
More informationOncocytic-Appearing Salivary Gland Tumors. Oncocytic, Cystic, Mucinous, and High Grade Salivary Gland Tumors SALIVARY GLAND FNA: PART II
William C. Faquin, MD, PhD Professor of Pathology Harvard Medical School Director of Head and Neck Pathology Massachusetts Eye and Ear Massachusetts General Hospital SALIVARY GLAND FNA: PART II Oncocytic,
More informationCase year old female presented with asymmetric enlargement of the left lobe of the thyroid
Case 4 22 year old female presented with asymmetric enlargement of the left lobe of the thyroid gland. No information available relative to a prior fine needle aspiration biopsy. A left lobectomy was performed.
More informationCase 4 Diagnosis 2/21/2011 TGB
Case 4 22 year old female presented with asymmetric enlargement of the left lobe of the thyroid gland. No information available relative to a prior fine needle aspiration biopsy. A left lobectomy was performed.
More informationAGGRESSIVE VARIANTS OF PAPILLARY THYROID CARCINOMA DIAGNOSIS AND PROGNOSIS
AGGRESSIVE VARIANTS OF PAPILLARY THYROID CARCINOMA DIAGNOSIS AND PROGNOSIS PAPILLARY THYROID CARCINOMA Clinical Any age Microscopic to large Female: Male= 2-4:1 Radiation history Lymph nodes Prognosis
More informationCase: The patient is a 24 year- old female who was found to have multiple mural nodules within the antrum. Solid and cystic components were noted on
Case: The patient is a 24 year- old female who was found to have multiple mural nodules within the antrum. Solid and cystic components were noted on imaging. There is no significant past medical history.
More informationEnterprise Interest Nothing to declare
Enterprise Interest Nothing to declare Diagnoses one would not like to miss in soft tissue pathology early in your career Marta Sbaraglia, MD Department of Pathology Hospital of Treviso University of Padua
More information21/07/2017. Hobnail endothelial cells are not the same as epithelioid endothelial cells
UPDATE IN CUTANEOUS VASCULAR S DERMATOPATHOLOGY SESSION BELFAST PATHOLOGY JUNE 21/2017 Dr E Calonje St John s Institute of Dermatology, London, United Kingdom THE FAMILY OF VASCULAR S WITH EPITHELIOID
More informationHereditary Leiomyomatosis and Renal Cell Carcinoma Variant of Reed s Syndrome - A Rare Case Report
American Research Journal of Urology Volume 1, Issue 1, pp:26-30 Case Hereditary Leiomyomatosis and Renal Cell Carcinoma Variant of Reed s Syndrome - A Rare Case Manas Babu, Devesh Bansal, Sony Mehta,
More informationFollicular Derived Thyroid Tumors
Follicular Derived Thyroid Tumors Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology Chair of Pathology and Laboratory Medicine University of Arkansas for Medical Sciences
More informationInternational Journal of Pharma and Bio Sciences CHROMOPHOBE VARIANT OF RENAL CELL CARCINOMA MASQUARDING AS RENAL ONCOCYTOMA ON CYTOLOGY.
Case Report Pathology International Journal of Pharma and Bio Sciences ISSN 0975-6299 CHROMOPHOBE VARIANT OF RENAL CELL CARCINOMA MASQUARDING AS RENAL ONCOCYTOMA ON CYTOLOGY. DR.MAMATHA K*, DR. ARAKERI
More informationLesions Mimicking Adenoid Cystic Carcinoma. Diagnostic Problems in Salivary Gland Pathology An Update 5/29/2009
Diagnostic Problems in Salivary Gland Pathology An Update Lesions Mimicking Adenoid Cystic Carcinoma Stacey E. Mills, M.D. W.S. Royster Professor of Pathology Director of Surgical and Cytopathology University
More informationUnknown Slides Conference
Unknown Slides Conference Jae Y. Ro, MD, PhD Weill Medical College of Cornell Univ. The Methodist Hospital, and UT MD Anderson Cancer Center Houston, TX November 9, 2013 Amman, Jordan 25 th Congress of
More information3/27/2017. Pulmonary Pathology Specialty Conference. Disclosure of Relevant Financial Relationships. Clinical History:
Pulmonary Pathology Specialty Conference Saul Suster, M.D. Medical College of Wisconsin Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position
More informationCYSTIC TUMORS OF THE KIDNEY JOHN N. EBLE, M.D. CYSTIC NEPHROMA
Page 1 CYSTIC TUMORS OF THE KIDNEY JOHN N. EBLE, M.D. Department of Pathology & Laboratory Medicine Phone (317) 274-4806 Medical Science A-128 FAX: (317) 278-2018 635 Barnhill Drive jeble @iupui.edu Indianapolis,
More informationProliferative Epithelial lesions of the Breast. Sami Shousha, MD, FRCPath Charing Cross Hospital & Imperial College, London
Proliferative Epithelial lesions of the Breast Sami Shousha, MD, FRCPath Charing Cross Hospital & Imperial College, London Amman, November2013 Proliferative Epithelial Lesions of the Breast Usual type
More informationCurrent insights in renal cell cancer pathology
Urologic Oncology: Seminars and Original Investigations 26 (2008) 225 238 Review article Current insights in renal cell cancer pathology Vito Mancini, M.D. a, *, Michele Battaglia, M.D. a, Pasquale Ditonno,
More informationACCME/Disclosures ALK FUSION-POSITIVE MESENCHYMAL TUMORS. Tumor types with ALK rearrangements. Anaplastic Lymphoma Kinase. Jason L.
Companion Meeting of the International Society of Bone and Soft Tissue Pathology The Evolving Concept of Mesenchymal Tumors ALK FUSION-POSITIVE MESENCHYMAL TUMORS Jason L. Hornick, MD, PhD March 13, 2016
More information57th Annual HSCP Spring Symposium 4/16/2016
An Unusual Malignant Spindle Cell Lesion to Involve the Breast Erinn Downs-Kelly, D.O. Associate Professor of Pathology University of Utah & ARUP Laboratories No disclosures Case 39 y/o female with no
More informationDisclosures. Parathyroid Pathology. Objectives. The normal parathyroid 11/10/2012
Disclosures Parathyroid Pathology I have nothing to disclose Annemieke van Zante MD/PhD Assistant Professor of Clinical Pathology Associate Chief of Cytopathology Objectives 1. Review the pathologic features
More information3/24/2017. Disclosure of Relevant Financial Relationships. Mixed Epithelial Endometrial Carcinoma. ISGyP Endometrial Cancer Project
Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position to influence or control the content of CME disclose any relevant financial relationship
More informationEvening Specialty Conference: Cytopathology
: Cytopathology N. Paul Ohori, M.D. University of Pittsburgh Medical Center Disclosure of Relevant Financial Relationships Disclosure of Relevant Financial Relationships USCAP requires that all planners
More informationCase Report Morphologic heterogeneity and markers of renal cell carcinoma with t(6; 11)(p21; q12): a case report and literature review
Int J Clin Exp Pathol 2017;10(12):11766-11770 www.ijcep.com /ISSN:1936-2625/IJCEP0065006 Case Report Morphologic heterogeneity and markers of renal cell carcinoma with t(6; 11)(p21; q12): a case report
More informationUSCAP 2012: Companion Meeting of the AAOOP. Update on lacrimal gland neoplasms: Molecular pathology of interest
USCAP 2012: Companion Meeting of the AAOOP Vancouver BC, Canada, March 17, 2012 Update on lacrimal gland neoplasms: Molecular pathology of interest Valerie A. White MD, MHSc, FRCPC Department of Pathology
More informationB. Environmental Factors. a. The major risk factor to papillary thyroid cancer is exposure to ionizing radiation, during the first 2 decades of life.
B. Environmental Factors. a. The major risk factor to papillary thyroid cancer is exposure to ionizing radiation, during the first 2 decades of life. b. Deficiency of dietary iodine: - Is linked with a
More informationBasement membrane in lobule.
Bahram Memar, MD Basement membrane in lobule. Normal lobule-luteal phase Normal lobule-follicular phase Lactating breast Greater than 95% are adenocarcinomas in situ carcinomas and invasive carcinomas.
More informationRENAL CELL CARCINOMA 2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow, Necrotic Mass with a Pseud
GENITOURINARY PATHOLOGY Kathleen M. O Toole Toole, M.D. RENAL CELL CARCINOMA 2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow, Necrotic Mass with a
More informationINTRADUCTAL LESIONS OF THE PROSTATE. Jonathan I. Epstein
INTRADUCTAL LESIONS OF THE PROSTATE Jonathan I. Epstein Topics Prostatic intraepithelial neoplasia (PIN) Intraductal adenocarcinoma (IDC-P) Intraductal urothelial carcinoma Ductal adenocarcinoma High Prostatic
More informationPRELIMINARY CYTOLOGIC DIAGNOSIS: Suspicious for Acinic Cell Carcinoma. Cell Block: Immunohistochemical Studies CYTOLOGIC DIAGNOSIS:
1 PRELIMINARY CYTOLOGIC DIAGNOSIS: Suspicious for Acinic Cell Carcinoma. Cell Block: Immunohistochemical Studies GCDFP-15 S-100 CYTOLOGIC DIAGNOSIS: Consistent with mammary analogue secretory carcinoma.
More informationAn Alphabet Soup of Thyroid Neoplasms
Overall Objectives An Alphabet Soup of Thyroid Neoplasms Lester D. R. Thompson www.lester-thompson.com What is the current management of papillary carcinoma? What are the trends and what can we do differently?
More informationCase Based Learning Program
Case Based Learning Program The Department of Urology Glickman Urological & Kidney Institute Cleveland Clinic Case Number 5 CBULP 2010 001 Case Based Urology Learning Program Editor: Associate Editor:
More information2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow, Necrotic Mass with a Pseudocapsule
GENITOURINARY PATHOLOGY Kathleen M. O Toole, M.D. Renal Cell Carcinoma 2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow Necrotic Mass Grossly is a Bright
More informationCASE year old male with a PET avid nodule in the left adrenal gland
CASE 1 55 year old male with a PET avid nodule in the left adrenal gland Case 1 Adrenal gland parenchyma partly replaced by a spindle cell tumour with mild nuclear pleomorphism Atypical mitoses present
More informationA Century of observations
PARAGANGLIOMAS OF THE HEAD & NECK: AN OVERVIEW Michelle D. Williams, MD Associate Professor Dept. of Pathology Head & Neck Section UT MD Anderson Cancer Center Disclosure of Relevant Financial Relationships
More informationDisclosure of Relevant Financial Relationships
Squamous entities of the thyroid: Reactive to Neoplastic Michelle D. Williams Associate Professor Dept of Pathology, Head & Neck Section University of Texas MD Anderson Cancer Center Disclosure of Relevant
More informationARTHUR PURDY STOUT SOCIETY COMPANION MEETING: DIFFICULT NEW DIFFERENTIAL DIAGNOSES IN PROSTATE PATHOLOGY. Jonathan I. Epstein.
1 ARTHUR PURDY STOUT SOCIETY COMPANION MEETING: DIFFICULT NEW DIFFERENTIAL DIAGNOSES IN PROSTATE PATHOLOGY Jonathan I. Epstein Professor Pathology, Urology, Oncology The Reinhard Professor of Urological
More informationRENAL EPITHELIAL TUMORS 2009: THE ROLE OF ELECTRON MICROSCOPY IN UNDERSTANDING PATHOGENESIS, DIAGNOSIS, AND CLASSIFICATION.
RENAL EPITHELIAL TUMORS 2009: THE ROLE OF ELECTRON MICROSCOPY IN UNDERSTANDING PATHOGENESIS, DIAGNOSIS, AND CLASSIFICATION. Guillermo A. Herrera MD Nephrocor, Tempe, Arizona Epithelial renal cell tumors
More informationPapillary Lesions of the Breast
Papillary Lesions of the Breast Laura C. Collins, M.D. Associate Professor of Pathology Associate Director, Division of Anatomic Pathology Beth Israel Deaconess Medical Center and Harvard Medical School
More informationof 20 to 80 and subsequently declines [2].
- - According to the 2014 World Health Organization (WHO) classification and tumor morphology, primary ovarian tumors are subdivided into three categories: epithelial (60%), germ cell (30%), and sex-cord
More informationSalivary Glands 3/7/2017
Salivary Glands 3/7/2017 Goals and objectives Focus on the entities unique to H&N Common board type facts Information for your future practice Salivary Glands Salivary Glands Major gland. Paratid. Submandibular.
More information04/10/2018. Intraductal Papillary Neoplasms Of Breast INTRADUCTAL PAPILLOMA
Intraductal Papillary Neoplasms Of Breast Savitri Krishnamurthy MD Professor of Pathology Deputy Division Head The University of Texas MD Anderson Cancer Center 25 th Annual Seminar in Pathology Pittsburgh,
More informationNote: The cause of testicular neoplasms remains unknown
- In the 15- to 34-year-old age group, they are the most common tumors of men. - Tumors of the testis are a heterogeneous group of neoplasms that include: I. Germ cell tumors : 95%; all are malignant.
More informationProblem 1: Differential of Neuroendocrine Carcinoma 3/23/2017. Disclosure of Relevant Financial Relationships
Differential of Neuroendocrine Carcinoma Alain C. Borczuk,MD Weill Cornell Medicine Disclosure of Relevant Financial Relationships USCAP requires that all faculty in a position to influence or control
More informationRenal Masses in Patients with Known Extrarenal Primary Primary Cancer Primary Primary n Met Mets s RCC Beni L mphoma Lung Breast Others
The Importance of Stuart G. Silverman, MD, FACR Professor of Radiology Harvard ard Medical School Director, Abdominal Imaging and Intervention Brigham and Women s Hospital Boston, MA The Importance of
More informationG3.02 The malignant potential of the neoplasm should be recorded. CG3.02a
G3.02 The malignant potential of the neoplasm should be recorded. CG3.02a Conventional adrenocortical neoplasm. Each of the below parameters is scored 0 when absent and 1 when present. 3 or more of these
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Tubulopapillary Histomorphology in Renal Neoplasms: A Diagnostic Dilemma with Review Atin Singhai
More informationCase: The patient is a 62 year old woman with a history of renal cell carcinoma that was removed years ago. A 2.4 cm liver mass was found on CT
Case: The patient is a 62 year old woman with a history of renal cell carcinoma that was removed years ago. A 2.4 cm liver mass was found on CT during follow- up. ALT, AST, Alk Phos and bilirubin were
More informationRenal Cell Carcinoma: Genetics & Imaging Srinivasa R Prasad University of Texas San Antonio
Renal Cell Carcinoma: Genetics & Imaging Srinivasa R Prasad University of Texas HSC @ San Antonio No financial disclosures Acknowledgements Dr. Peter Choyke, NIH My Gurus @ MIR, MGH 2004 WHO Taxonomy of
More informationRCC in ADPKD / CKD / ESRD
RCC in ADPKD / CKD / ESRD FOIU 2018 David A. Goldfarb, MD,FACS Professor of Surgery, Cleveland Clinic Lerner College of Medicine Glickman Urological and Kidney Institute Cleveland Clinic, Cleveland, Ohio
More informationTHE PATHOLOGY OF COMMON RENAL TUMORS. Victor E. Reuter, M.D Memorial Sloan Kettering Cancer Center
THE PATHOLOGY OF COMMON RENAL TUMORS Victor E. Reuter, M.D Memorial Sloan Kettering Cancer Center A Practical Approach to Genitourinary Pathology Firenze, Italy May, 2016 Disclosures: none 1970 WHO classification:
More informationHow does histology alter treatment? Cora N. Sternberg, MD, FACP Department of Medical Oncology San Camillo and Forlanini Hospitals Rome, Italy
How does histology alter treatment? Cora N. Sternberg, MD, FACP Department of Medical Oncology San Camillo and Forlanini Hospitals Rome, Italy Targeting VHL/HIF in Clear Cell RCC VHL Bevacizumab (Antibody)
More informationPitfalls in the diagnosis of well-differentiated hepatocellular lesions
2013 Colorado Society of Pathology Pitfalls in the diagnosis of well-differentiated hepatocellular lesions Sanjay Kakar, MD University of California, San Francisco Outline Hepatocellular adenoma: new WHO
More informationthe urinary system pathology Dr. Fairoz A Eltorgman
the urinary system pathology Dr. Fairoz A Eltorgman Tumors of the renal pelvis & kidney Benign tumors of the renal pelvis: Hemangioma Leiomyoma Malignant tumors: Transitional cell carcinoma Squamous cell
More information3/24/2017 DENDRITIC CELL NEOPLASMS: HISTOLOGY, IMMUNOHISTOCHEMISTRY, AND MOLECULAR GENETICS. Disclosure of Relevant Financial Relationships
DENDRITIC CELL NEOPLASMS: HISTOLOGY, IMMUNOHISTOCHEMISTRY, AND MOLECULAR GENETICS Jason L. Hornick, M.D., Ph.D. Director of Surgical Pathology and Immunohistochemistry Brigham and Women s Hospital Professor
More informationTHYMIC CARCINOMAS AN UPDATE
THYMIC CARCINOMAS AN UPDATE Mark R. Wick, M.D. University of Virginia Medical Center Charlottesville, VA CARCINOMA OF THE THYMUS General Clinical Features No apparent gender predilection Age range of 35-75
More informationImmunoexpression of napsin a in renal neoplasms
Zhu et al. Diagnostic Pathology (2015) 10:4 DOI 10.1186/s13000-015-0242-z RESEARCH Open Access Immunoexpression of napsin a in renal neoplasms Bing Zhu, Stephen M Rohan and Xiaoqi Lin * Abstract Background:
More informationNormal thyroid tissue
Thyroid Pathology Overview Normal thyroid tissue Normal thyroid tissue with follicles filled with colloid. Thyroid cells form follicles, spheres of epithelial cells (always single layered in health, usually
More informationCN 925/15 History. Microscopic Findings
CN 925/15 History 78 year old female. FNA indeterminate lesion right thyroid lobe. Previous THY1C (UK) Bethesda category 1 cyst fluid. Ultrasound showed part solid/cystic changes, indeterminate in nature
More informationMammary analogue secretory carcinoma of salivary gland A case report of new entity
Case Report Mammary analogue secretory carcinoma of salivary gland A case report of new entity Vaibhav Bhika Bari 1*, Sandhya Unmesh Bholay 2 1 Assistant Professor, 2 Associate Professor Rajiv Gandhi Medical
More informationCase 2. Dr. Sathima Natarajan M.D. Kaiser Permanente Medical Center Sunset
Case 2 Dr. Sathima Natarajan M.D. Kaiser Permanente Medical Center Sunset History 24 year old male presented with a 3 day history of right flank pain, sharp in nature Denies fever, chills, hematuria or
More informationPSA. HMCK, p63, Racemase. HMCK, p63, Racemase
Case 1 67 year old male presented with gross hematuria H/o acute prostatitis & BPH Urethroscopy: small, polypoid growth with a broad base emanating from the left side of the verumontanum Serum PSA :7 ng/ml
More informationDiplomate of the American Board of Pathology in Anatomic and Clinical Pathology
A 33-year-old male with a left lower leg mass. Contributed by Shaoxiong Chen, MD, PhD Assistant Professor Indiana University School of Medicine/ IU Health Partners Department of Pathology and Laboratory
More informationCase Report Clear Cell Adenocarcinoma of the Renal Pelvis in a Male Patient
Case Reports in Pathology Volume 2013, Article ID 494912, 4 pages http://dx.doi.org/10.1155/2013/494912 Case Report Clear Cell Adenocarcinoma of the Renal Pelvis in a Male Patient Sarawut Kongkarnka, 1
More informationCase 1. Clinical history
Case 1 Case 1 Clinical history 17-month-old boy with a kidney tumor found during routine childhood care program. CT scan showed a solid mass. Chemotherapy was given for 4 weeks using actinomycin D and
More informationPresenter: Yeh-Han Wang M.D.
Korea-Taiwan-Japan Joint Meeting for Gynecological Pathology Mini-lecture Female Adnexal Tumor of Probable Wolffian Origin (FATWO) in Taiwan: A Small Case Series and Literature Review Presenter: Yeh-Han
More informationPOORLY DIFFERENTIATED, HIGH GRADE AND ANAPLASTIC CARCINOMAS: WHAT IS EVERYONE TALKING ABOUT?
POORLY DIFFERENTIATED, HIGH GRADE AND ANAPLASTIC CARCINOMAS: WHAT IS EVERYONE TALKING ABOUT? AGGRESSIVE THYROID CANCERS PAPILLARY CARCINOMA CERTAIN SUBTYPES POORLY DIFFERENTIATED CARCINOMA HIGH GRADE DIFFERENTIATED
More informationCorrespondence should be addressed to I. Sokolakis;
Hindawi Case Reports in Urology Volume 2017, Article ID 6597592, 4 pages https://doi.org/10.1155/2017/6597592 Case Report Mucin-Poor Mucinous Tubular and Spindle Cell Carcinoma of the Kidney Presented
More informationTumors of kidney and urinary bladder
Tumors of kidney and urinary bladder Overview of kidney tumors Benign and malignant Of the benign: papillary adenoma -cortical -small (0.5cm) -in 40% of population -clinically insignificant The most common
More informationNeuroendocrine Lung Tumors Myers
Diagnosis and Classification of Neuroendocrine Lung Tumors Jeffrey L. Myers, M.D. A. James French Professor Director, Anatomic Pathology & MLabs University of Michigan, Ann Arbor, MI myerjeff@umich.edu
More information